Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2519)
All Articles published online
|
Jun 21, 2006 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Mathonnet M, Descottes B, Valleix D, Labrousse F, Truffinet V, Denizot Y. Quantitative analysis using ELISA of vascular endothelial growth factor and basic fibroblast growth factor in human colorectal cancer, liver metastasis of colorectal cancer and hepatocellular carcinoma. World J Gastroenterol 2006; 12(23): 3782-3783 [PMID: 16773701 DOI: 10.3748/wjg.v12.i23.3782] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i23/3782.htm |
| Number | Citing Articles |
| 1 |
A. R. Rama, A. Aguilera, C. Melguizo, O. Caba, J. Prados. Tissue Specific Promoters in Colorectal Cancer. Disease Markers 2015; 2015: 1 doi: 10.1155/2015/390161
|
| 2 |
Dong-Xun Zhou, Long-Yi Zheng, Hai-Xia Qu, Feng-Hai Yu, Shan-Shan Zou, Yi Hong, Ye-Xiong Tan, Hao Wang, He-Ping Hu, Hong-Yang Wang. Identification and differential expression of human carcinoma-associated antigens in hepatocellular carcinoma tissues. Experimental Biology and Medicine 2013; 238(2): 167 doi: 10.1177/1535370212474599
|
| 3 |
Feng DUAN, Mao Qiang WANG, Feng Yong LIU, Zhi Jun WANG, Peng SONG, Yan WANG. Sorafenib in combination with transarterial chemoembolization and bronchial arterial chemoinfusion in the treatment of hepatocellular carcinoma with pulmonary metastasis. Asia-Pacific Journal of Clinical Oncology 2012; 8(2): 156 doi: 10.1111/j.1743-7563.2012.01542.x
|
| 4 |
Leida Zhang, Peng Hu, Xi Chen, Ping Bie, Lian-Yue Yang. Transarterial Chemoembolization (TACE) plus Sorafenib Versus TACE for Intermediate or Advanced Stage Hepatocellular Carcinoma: A Meta-Analysis. PLoS ONE 2014; 9(6): e100305 doi: 10.1371/journal.pone.0100305
|
| 5 |
Zhoujing Cheng, Lin He, Yingjie Guo, Yuhua Song, Shasha Song, Lijiu Zhang. The combination therapy of transarterial chemoembolisation and sorafenib is the preferred palliative treatment for advanced hepatocellular carcinoma patients: a meta-analysis. World Journal of Surgical Oncology 2020; 18(1) doi: 10.1186/s12957-020-02017-0
|
| 6 |
Wei Bai, Yong Ji Wang, Yan Zhao, Xing Shun Qi, Zhan Xin Yin, Chuang Ye He, Rui Jun Li, Kai Chun Wu, Jie Lai Xia, Dai Ming Fan, Guo Hong Han. Sorafenib in combination with transarterial chemoembolization improves the survival of patients with unresectable hepatocellular carcinoma: A propensity score matching study. Journal of Digestive Diseases 2013; 14(4): 181 doi: 10.1111/1751-2980.12038
|
| 7 |
Bo Zhou, Zhiping Yan, Rong Liu, Peng Shi, Sheng Qian, Xudong Qu, Liang Zhu, Wei Zhang, Jianhua Wang. Prospective Study of Transcatheter Arterial Chemoembolization (TACE) with Ginsenoside Rg3 versus TACE Alone for the Treatment of Patients with Advanced Hepatocellular Carcinoma. Radiology 2016; 280(2): 630 doi: 10.1148/radiol.2016150719
|
| 8 |
Yunxia Yuan, Huichun Yu, Yong Yin. A highly sensitive aptasensor for vascular endothelial growth factor based on fluorescence resonance energy transfer from upconversion nanoparticles to MoS2 nanosheets. Analytical Methods 2020; 12(36): 4466 doi: 10.1039/D0AY01067G
|
| 9 |
Jing Chen, Chengya Zhou, Yu Long, Xude Yin. Sunitinib combined with transarterial chemoembolization versus transarterial chemoembolization alone for advanced-stage hepatocellular carcinoma: a propensity score matching study. Tumor Biology 2015; 36(1): 183 doi: 10.1007/s13277-014-2608-3
|
| 10 |
Yves Denizot, Rafael De Armas, François Caire, Jean Jacques Moreau, Isabelle Pommepuy, Véronique Truffinet, François Labrousse. The Quantitative Analysis of bFGF and VEGF by ELISA in Human Meningiomas. Mediators of Inflammation 2006; 2006(1) doi: 10.1155/MI/2006/36376
|
| 11 |
Magda Nasr, Eman Selima, Omar Hamed, Amany Kazem. Targeting different angiogenic pathways with combination of curcumin, leflunomide and perindopril inhibits diethylnitrosamine-induced hepatocellular carcinoma in mice. European Journal of Pharmacology 2014; 723: 267 doi: 10.1016/j.ejphar.2013.11.022
|
| 12 |
YONGXU MU, JUNFENG HE, RUIQIANG YAN, XIAOYAN HU, HAIYAN LIU, ZHIMING HAO. IGF-1 and VEGF can be used as prognostic indicators for patients with uterine fibroids treated with uterine artery embolization. Experimental and Therapeutic Medicine 2016; 11(2): 645 doi: 10.3892/etm.2015.2924
|
| 13 |
Wenjiao Zeng, Annette S.H. Gouw, Marius C. van den Heuvel, Peter J. Zwiers, Pieter E. Zondervan, Sibrand Poppema, Nong Zhang, Inge Platteel, Koert P. de Jong, Grietje Molema. The angiogenic makeup of human hepatocellular carcinoma does not favor vascular endothelial growth factor/angiopoietin-driven sprouting neovascularization. Hepatology 2008; 48(5): 1517 doi: 10.1002/hep.22490
|